Karolinska University Hospital / Karolinska Universitetssjukhuset

Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe (2022) Nowotny H, Neumann U, Tardy-Guidollet V, Faisal Ahmed S, Baronio F, Battelino T, Bertherat J, et al. Journal article Rheumatic?—A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A Multicenter Pilot Validation Study (2022) Knevel R, Knitza J, Hensvold A, Circiumaru A, Bruce T, Evans S, Maarseveen T, et al. Journal article First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B (2022) Gehlen J, Giel AS, Köllges R, Haas SL, Zhang R, Trcka J, Sungur A, et al. Journal article Results from a multicentre evaluation of plug use for left ventricular assist device explantation (2022) Potapov EV, Politis N, Karck M, Weyand M, Tandler R, Walther T, Emrich F, et al. Journal article COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies (2022) Gil-Vila A, Ravichandran N, Selva-O'Callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, et al. Journal article Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation Study (2022) Lang-Schwarz C, Rubio CA, Vieth M Journal article Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions (2021) Dias DO, Kalkitsas J, Kelahmetoglu Y, Estrada CP, Tatarishvili J, Holl D, Jansson L, et al. Journal article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes (2021) Tsekrekos A, Vieth M, Ndegwa N, Bateman A, Flejou JF, Grabsch H, Mastracci L, et al. Journal article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution